| 18th Annual Scientific Meeting of the International Society for Biological Therapy of Cancer. 30 October-2 November 2003, Bethesda, Maryland, USA. | |
| | |
MedLine Citation:
|
PMID: 14680473 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
The 18th Annual Scientific Meeting of the International Society for Biological Therapy of Cancer (iSBTc) was held at the Hyatt Regency, Bethesda, MD, close to the National Institutes of Health (NIH) campus. The meeting was organised on behalf of the society by Neil Berinstein from Aventis Pasteur, Toronto, Canada, Janice P Dutcher from Our Lady of Mercy Medical Center, Bronx, NY and Francesco M Marincola from the NIH, Bethesda, MD. The 2003 meeting included 57 oral presentations and > 100 poster presentations. There were > 800 registrants to the Annual Meeting and the multiple satellite symposia. The iSBTc, formerly the Society of Biological Therapy (SBT), was founded by R Oldham in 1984. Its membership has been rapidly growing of late, with > 500 members at present. The purpose of the iSBTc is to bring together those diverse individuals actively investigating biologic agents and biological response modifiers in the treatment of cancer, including clinicians and basic scientists from industry, government and academia. The President of the Society is Dr Michael B Atkins from Beth Israel Deaconess Medical Center, Boston, MA and the Vice President is Ulrich Keilholz from UKBF, Free University Berlin, Germany. |
| | |
Authors:
|
Francesco M Marincola; Ena Wang; Michael B Atkins |
Related Documents
:
|
1102873 - Role of scientific societies in disseminating knowledge and fostering research on x-rays. 16575543 - Documentary bioethics: visual narratives for generations x and y. 10276173 - Joint ventures in health care: more than a sideline business. |
Publication Detail:
|
Type: Congresses |
Journal Detail:
|
Title: Expert opinion on biological therapy Volume: 4 ISSN: 1471-2598 ISO Abbreviation: Expert Opin Biol Ther Publication Date: 2004 Jan |
Date Detail:
|
Created Date: 2003-12-18 Completed Date: 2004-07-20 Revised Date: 2004-11-17 |
Medline Journal Info:
|
Nlm Unique ID: 101125414 Medline TA: Expert Opin Biol Ther Country: England |
Other Details:
|
Languages: eng Pagination: 107-14 Citation Subset: IM |
Affiliation:
|
Immunogenetics Section, Department of Transfusion Medicine, Clinical Center, NIH, Bldg 10, R-1C711, 9000 Rockville Pike, Bethesda, MD 20892, USA. FMarincola@cc.nih.gov |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Animals Biological Therapy / trends* Gene Therapy / trends Humans Immunotherapy, Adoptive / trends Internationality Monitoring, Immunologic / trends Neoplasms / immunology, therapy* Societies, Medical |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Antibody-based treatment of acute myeloid leukaemia.
Next Document: Ubiquinone is not required for proton conductance by uncoupling protein 1 in yeast mitochondria.